MartÃnez, Laura E.
Lensing, Shelly
Chang, Di
Magpantay, Larry I.
Guo, Yu
Mitsuyasu, Ronald
Ambinder, Richard F.
Sparano, Joseph A.
MartÃnez-Maza, Otoniel
Epeldegui, Marta
Funding for this research was provided by:
National Cancer Institute (R01-CA228157S, UM1-CA121947, UM1-CA121947, UM1-CA121947, R01-CA228157, UM1-CA121947, UM1-CA121947, UM1-CA121947, UM1-CA121947, R01-CA228157)
Article History
Received: 4 November 2024
Accepted: 8 July 2025
First Online: 12 July 2025
Declarations
:
: The authors declare no competing interests.
: The study was reviewed and approved by the Cancer Evaluation Therapy Program of the National Cancer Institute, and by the institutional review board at each participating institution. All patients provided written informed consent and this study was performed in accordance with the Declaration of Helsinki. Specimens and data were obtained from the AIDS and Cancer Specimen Resource (ACSR) repository under The George Washington University Committee on Human Research, Institutional Review Board (IRB), FWA00005945 IRB# NCR191593.